Skip to main content
. 2014 Aug 13;8:93. doi: 10.1186/s12918-014-0093-3

Figure 2.

Figure 2

Grouping topics by the number of significantly enriched KEGG pathways. The pie chart above each bar shows the percentage of samples assayed in in vitro (blue), in vivo single dose treatment (green) and in vivo repeated dose treatment (red).